retatrutide phase 2 trial type 2 diabetes weight loss 2024 VisualAbstract: reduces body by 17.5% in patients with obesity Phase III retatrutide study demonstrates

All research compounds, including retatrutide, must be used strictly in controlled laboratory settings by qualified research professionals

Use alcohol-free alternatives like Biotene Dry Mouth Oral Rinse, CloSYS, or ACT Dry Mouth Rinse instead

For perspective on where this lands against the field (placebo-adjusted weight loss): Type 2 diabetes TRANSCEND-T2D-1 (n = 537, 40 weeks) Published simultaneously in The Lancet

It comes from your gut and helps your body process sugar in two big ways

If you want a broader explanation of this drug family, the GLP-1 Explained article gives useful context on how incretin medicines fit into diabetes and weight management care

Potential Impact: If 2.4mg/2.4mg achieves 20.4% weight loss, could 2.4mg/7.2mg achieve 25-27%